BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25514992)

  • 1. Inhibition of Alzheimer's amyloid-β peptide aggregation and its disruption by a conformationally restricted α/β hybrid peptide.
    Paul A; Nadimpally KC; Mondal T; Thalluri K; Mandal B
    Chem Commun (Camb); 2015 Feb; 51(12):2245-8. PubMed ID: 25514992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure inducing ionic liquids-enhancement of alpha helicity in the Abeta(1-40) peptide from Alzheimer's disease.
    Debeljuh N; Barrow CJ; Henderson L; Byrne N
    Chem Commun (Camb); 2011 Jun; 47(22):6371-3. PubMed ID: 21547327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effects of pH, Cu+2 and sheet breakers on aggregation of amyloid peptides.
    Beking K; Hao X; Basak S; Basak A
    Protein Pept Lett; 2005 Feb; 12(2):197-202. PubMed ID: 15723646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid.
    Huang TH; Yang DS; Fraser PE; Chakrabartty A
    J Biol Chem; 2000 Nov; 275(46):36436-40. PubMed ID: 10961999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural dynamics of the ΔE22 (Osaka) familial Alzheimer's disease-linked amyloid β-protein.
    Inayathullah M; Teplow DB
    Amyloid; 2011 Sep; 18(3):98-107. PubMed ID: 21668291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Cu-amyloid-β by using bifunctional peptides with β-sheet breaker and chelator moieties.
    Jensen M; Canning A; Chiha S; Bouquerel P; Pedersen JT; Østergaard J; Cuvillier O; Sasaki I; Hureau C; Faller P
    Chemistry; 2012 Apr; 18(16):4836-9. PubMed ID: 22422637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
    McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
    Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between amyloid beta peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide.
    Rezaei-Ghaleh N; Andreetto E; Yan LM; Kapurniotu A; Zweckstetter M
    PLoS One; 2011; 6(5):e20289. PubMed ID: 21633500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TANGO-Inspired Design of Anti-Amyloid Cyclic Peptides.
    Lu X; Brickson CR; Murphy RM
    ACS Chem Neurosci; 2016 Sep; 7(9):1264-74. PubMed ID: 27347598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.
    Gordon DJ; Sciarretta KL; Meredith SC
    Biochemistry; 2001 Jul; 40(28):8237-45. PubMed ID: 11444969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of β-sheet breaker peptides on metal associated Amyloid-β peptide aggregation process.
    Stellato F; Fusco Z; Chiaraluce R; Consalvi V; Dinarelli S; Placidi E; Petrosino M; Rossi GC; Minicozzi V; Morante S
    Biophys Chem; 2017 Oct; 229():110-114. PubMed ID: 28527974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper abolishes the beta-sheet secondary structure of preformed amyloid fibrils of amyloid-beta(42).
    House E; Mold M; Collingwood J; Baldwin A; Goodwin S; Exley C
    J Alzheimers Dis; 2009; 18(4):811-7. PubMed ID: 19749401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions.
    McLaurin J; Fraser PE
    Eur J Biochem; 2000 Nov; 267(21):6353-61. PubMed ID: 11029577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide: Abeta association kinetics at endosomal pH.
    Gorman PM; Yip CM; Fraser PE; Chakrabartty A
    J Mol Biol; 2003 Jan; 325(4):743-57. PubMed ID: 12507477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease.
    Hou L; Kang I; Marchant RE; Zagorski MG
    J Biol Chem; 2002 Oct; 277(43):40173-6. PubMed ID: 12198111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
    Sharma S; Nehru B; Saini A
    Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
    Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
    Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregation of Beta-Amyloid Peptides Proximal to Zwitterionic Lipid Bilayers.
    Yang CI; Tsai BN; Huang SJ; Wang TY; Tai HC; Chan JC
    Chem Asian J; 2015 Sep; 10(9):1967-71. PubMed ID: 26097047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.